| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9320144 | European Urology | 2005 | 5 Pages |
Abstract
This preliminary study shows that the combination of MRI and MRSI might be able to guide and therefore limit the number of iterative biopsies and cores for patients who are at high risk of having a prostate cancer. In some cases, MRSI alone allows identification of neoplasic prostatic zones. Other studies are needed to confirm these data.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Delphine Amsellem-Ouazana, Patrick Younes, Sophie Conquy, Mickaël Peyromaure, Thierry Flam, Bernard Debré, Marc Zerbib,